Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A PEG Ratio

The latest PEG ratio for FBIOP is -0.55. That is above the Healthcare sector average of -5.81. Investors often review this figure alongside Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, FBIOP currently prints -0.55 for PEG ratio, while the sector average sits near -5.81. That is roughly 90.6% above the sector mean. Large gaps often invite a closer look at Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A's growth, margins, and balance sheet.

A PEG ratio of -0.55 for Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A is not 'good' or 'bad' on its own. Compare it with the peer average (-5.81) and with FBIOP's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting FBIOP's PEG ratio (-0.55), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.